Eurofins Scientific SE Total Liabilities
Eurofins Scientific SE total liabilities. Based on the latest financial reports, Eurofins Scientific SE (ERF) has total liabilities worth €7.40 Billion EUR (≈ $8.65 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Eurofins Scientific SE liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Eurofins Scientific SE (2002–2025)
Total liabilities of Eurofins Scientific SE from 2002 to 2025. This chart illustrates how Eurofins Scientific SE's total liabilities have evolved over time, based on quarterly financial data. Explore Eurofins Scientific SE long-term investment allocation to see how much of total assets are deployed in long-term investments.
Eurofins Scientific SE Competitors by Total Liabilities
The table below lists competitors of Eurofins Scientific SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alcoa Corp
NYSE:AA
|
USA | $9.54 Billion |
|
Persistent Systems Limited
NSE:PERSISTENT
|
India | Rs31.39 Billion |
|
China Southern Airlines Co Ltd Class A
SHG:600029
|
China | CN¥299.35 Billion |
|
The AES Corporation
NYSE:AES
|
USA | $43.46 Billion |
|
AtkinsRealis Group Inc
TO:ATRL
|
Canada | CA$6.99 Billion |
|
FactSet Research Systems Inc
NYSE:FDS
|
USA | $2.14 Billion |
|
China Pacific Insurance (Group) Co. Ltd
F:75C
|
Germany | €2.87 Trillion |
Liability Composition Analysis (2002–2025)
This chart breaks down Eurofins Scientific SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Eurofins Scientific SE (ERF) total assets.
Liquidity & Leverage Metrics
Eurofins Scientific SE Total Liabilities Ratios Explained
Eurofins Scientific SE total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.33 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurofins Scientific SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurofins Scientific SE (2002–2025)
The table below shows the annual total liabilities of Eurofins Scientific SE from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €7.40 Billion ≈ $8.65 Billion |
+34.44% |
| 2024-12-31 | €5.50 Billion ≈ $6.43 Billion |
-4.31% |
| 2023-12-31 | €5.75 Billion ≈ $6.72 Billion |
+9.91% |
| 2022-12-31 | €5.23 Billion ≈ $6.12 Billion |
+12.40% |
| 2021-12-31 | €4.66 Billion ≈ $5.44 Billion |
-4.20% |
| 2020-12-31 | €4.86 Billion ≈ $5.68 Billion |
-1.34% |
| 2019-12-31 | €4.92 Billion ≈ $5.76 Billion |
+9.85% |
| 2018-12-31 | €4.48 Billion ≈ $5.24 Billion |
+33.82% |
| 2017-12-31 | €3.35 Billion ≈ $3.92 Billion |
+41.20% |
| 2016-12-31 | €2.37 Billion ≈ $2.77 Billion |
-9.42% |
| 2015-12-31 | €2.62 Billion ≈ $3.06 Billion |
+116.68% |
| 2014-12-31 | €1.21 Billion ≈ $1.41 Billion |
+9.68% |
| 2013-12-31 | €1.10 Billion ≈ $1.29 Billion |
+40.78% |
| 2012-12-31 | €782.97 Million ≈ $915.38 Million |
+3.81% |
| 2011-12-31 | €754.26 Million ≈ $881.81 Million |
+49.22% |
| 2010-12-31 | €505.47 Million ≈ $590.95 Million |
+10.78% |
| 2009-12-31 | €456.26 Million ≈ $533.42 Million |
-11.39% |
| 2008-12-31 | €514.89 Million ≈ $601.96 Million |
+29.87% |
| 2007-12-31 | €396.46 Million ≈ $463.50 Million |
+10.84% |
| 2006-12-31 | €357.70 Million ≈ $418.19 Million |
+94.67% |
| 2005-12-31 | €183.75 Million ≈ $214.82 Million |
+48.15% |
| 2004-12-31 | €124.03 Million ≈ $145.00 Million |
+10.12% |
| 2003-12-31 | €112.63 Million ≈ $131.67 Million |
+4.91% |
| 2002-12-31 | €107.35 Million ≈ $125.51 Million |
-- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more